Advertisement
Screener

DNA X, Inc. (SONM) Overview

DNA X, Inc. (SONM) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.92; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 5.01; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -4.83; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -14.15; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$1.97$2.83$4.07$5.85$8.41$12.102025-11-062026-11-06$0.50$0.95$1.80$3.41$6.47$12.262025-05-092026-11-06$0.50$0.95$1.80$3.41$6.47$12.262025-05-092026-11-06$0.50$0.95$1.80$3.41$6.47$12.262025-05-092026-11-06$0.50$0.95$1.80$3.41$6.47$12.262025-05-092026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$2.07
Previous close
$3.85
Change
-$1.79
Change (%)
-46.30%
Close date
2026-11-06
Previous close date
2026-09-24
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · (m)

YTD

SONM
(m)
S&P 500
(m)

1 year

SONM
(m)
S&P 500
(m)

3 years

SONM
(m)
S&P 500
(m)

5 years

SONM
(m)
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.92

-14.23-9.38-4.520.345.1931 Mar 2025: estimate (m); actual 1.4131 Mar 2025(m)30 Jun 2025: estimate (m); actual -14.1530 Jun 2025(m)30 Sept 2025: estimate (m); actual -4.8330 Sept 2025(m)31 Mar 2026: estimate (m); actual 5.0131 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.9230 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.92(m)(m)
1 Jan 202631 Mar 2026(m)5.01(m)(m)
1 Jul 202530 Sept 2025(m)-4.83(m)(m)
1 Apr 202530 Jun 2025(m)-14.15(m)(m)
1 Jan 202531 Mar 2025(m)1.41(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -28.58

-128.45-96.30-64.15-31.990.1631 Dec 2022: estimate (m); actual -0.4931 Dec 2022(m)31 Dec 2023: estimate (m); actual -0.0231 Dec 2023(m)31 Dec 2024: estimate (m); actual -128.3731 Dec 2024(m)31 Dec 2025: estimate (m); actual -28.5831 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-28.58(m)(m)
1 Jan 202431 Dec 2024(m)-128.37(m)(m)
1 Jan 202331 Dec 2023(m)-0.02(m)(m)
1 Jan 202231 Dec 2022(m)-0.49(m)(m)

Revenue vs. Earnings

USD

30 Sept 2025 ■ Revenue 16.21M ■ Earnings -4.75M — Profit margin -29.31%

-10.38M-67.8%-0.38M-44.0%9.62M-20.1%19.62M3.7%30 Sept 2024: revenue 15.02M; earnings -2.51M; profit margin -16.72%30 Sept 202431 Mar 2025: revenue 16.72M; earnings 0.46M; profit margin 2.74%31 Mar 202530 Jun 2025: revenue 11.19M; earnings -7.47M; profit margin -66.80%30 Jun 202530 Sept 2025: revenue 16.21M; earnings -4.75M; profit margin -29.31%30 Sept 2025

31 Dec 2024 ■ Revenue 50.92M ■ Earnings -33.65M — Profit margin -66.08%

-54.50M-71.8%0.17M-47.6%54.84M-23.3%109.50M0.9%31 Dec 2021: revenue 54.57M; earnings -38.63M; profit margin -70.78%31 Dec 202131 Dec 2022: revenue 69.83M; earnings -14.09M; profit margin -20.17%31 Dec 202231 Dec 2023: revenue 93.63M; earnings -0.09M; profit margin -0.10%31 Dec 202331 Dec 2024: revenue 50.92M; earnings -33.65M; profit margin -66.08%31 Dec 2024

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$2.07(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$2.07High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning SONM

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Sept 2025.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-33.38M
Profit margin
-56.21%
Return on assets · 12 month
-74.71%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
403.00
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
21.24K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
(m)
Total return · month
(m)
Total return · quarter
(m)
Total return · half year
(m)
Total return · year to date
(m)
Total return · 1 year
(m)
Total return · 3 years
(m)
Total return · 5 years
(m)
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$59.39M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
-722.82%*
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

DNA X, Inc. Overview

View more →

(m)

(m)

SEC CIK
1178697
Industry (SIC)
3661 Telephone & Telegraph Apparatus
Country of operation
United States
Business address
4445 EASTGATE MALL, SUITE 200, SAN DIEGO, California, 92121, United States
Fiscal year end
1231
Phone
650-378-8100

Similar stocks

Stock NameCountryMarket CapPE Ratio
CLEARONE INC (CLRO)United States$0.009B
FRANKLIN WIRELESS CORP (FKWL)United States$0.028B-61.80
FiEE, Inc. (FIEE)Japan$0.033B8.06
Clearfield, Inc. (CLFD)United States$0.415B-74.88
ADTRAN Holdings, Inc. (ADTN)United States$0.565B-43.25
Fabrinet (FN)$14.287B39.79
CIENA CORP (CIEN)United States$50.874B81.72